Grand Rapids, MI

Grand Rapids, Michigan 49546

0 studies enrolling now · 2 studies all time

What they study most

Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration

Studies at this site

• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 — Completed